Simon Quick Advisors’s Nektar Therapeutics NKTR Stock Holding History

Simon Quick Advisors’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1	Closed	-$1K	–	429
2018 Q4	$1K	Buy	+1	New	+$604	﹤0.01%	316

Other funds holding NKTR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Simon Quick Advisors's NKTR Position: Q1 2019 in Review

Simon Quick Advisors sold out of Nektar Therapeutics (NKTR) in Q1 2019, closing a stake of 1 share — an estimated $1K sold.

Simon Quick Advisors first reported a position in NKTR in Q4 2018 and held it in 1 quarter. The position peaked at $1K in Q4 2018. 350 funds tracked by Wall St. Rank hold NKTR as of Q1 2019.

Simon Quick Advisors reported no remaining Nektar Therapeutics position as of Q1 2019 after selling out during the quarter.
Simon Quick Advisors sold 1 Nektar Therapeutics share in Q1 2019, an estimated $1K.
Simon Quick Advisors first reported a position in Nektar Therapeutics in Q4 2018 and held it in 1 quarter.
Simon Quick Advisors's Nektar Therapeutics position peaked at $1K in Q4 2018.
350 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2019.

Based on Simon Quick Advisors's 13F filing for Q1 2019, filed 16 Apr 2019.